{"originalText": "，患者3月前因“直肠癌”于在我院于全麻上行直肠癌根治术（DIXON术），手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好，切口愈合良好。，术后病理示：直肠腺癌（中低度分化），浸润溃疡型，面积3.5*2CM，侵达外膜。双端切线另送“近端”、“远端”及环周底部切除面未查见癌。肠壁一站（10个）、中间组（8个）淋巴结未查见癌。，免疫组化染色示：ERCC1弥漫（+）、TS少部分弱（+）、SYN（-）、CGA（-）。术后查无化疗禁忌后给予3周期化疗，，方案为：奥沙利铂150MG D1，亚叶酸钙0.3G+替加氟1.0G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，患者副反应轻。院外期间患者一般情况好，无恶心，无腹痛腹胀胀不适，无现患者为行复查及化疗再次来院就诊，门诊以“直肠癌术后”收入院。   近期患者精神可，饮食可，大便正常，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 11}, {"label_type": "手术", "overlap": 0, "start_pos": 21, "end_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 78, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 159}, {"end_pos": 234, "label_type": "药物", "overlap": 0, "start_pos": 230}, {"end_pos": 247, "label_type": "药物", "overlap": 0, "start_pos": 243}, {"end_pos": 255, "label_type": "药物", "overlap": 0, "start_pos": 252}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 276, "end_pos": 277}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 312, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 314, "end_pos": 315}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 342, "end_pos": 347}]}
{"originalText": "，患者因罹患“胃癌”于2013-10-29在我院予行全麻上胃癌根治术，，术中见：腹腔内腹水，腹膜无转移，肝脏未触及明显转移性灶，肿瘤位于胃体、胃底部，小弯侧偏后壁，约5*4*2CM大小，肿瘤已侵达浆膜外，第1、3组淋巴结肿大，肿瘤尚能活动，经探查决定行全胃切除，空肠J字代胃术。手术顺利，术后积极予相关对症支持治疗；，后病理示：胃底、体小弯侧低分化腺癌，部分为印戒细胞癌图像，蕈伞型，面积5.2*3.5CM，局部侵达粘膜上层，并于少数腺管内查见癌栓。双端切线及另送“近端切线”未查见癌。呈三组（5/13个）淋巴结癌转移。一组（7个）、四组（13个）、五组（1个）、六组（4个）淋巴结未查见癌。，癌组织免疫组化染色示：ERCC1（+）、β-TUBULIN-III（+）、TS（-）、RRM1（-）、TOPOII阳性细胞数约20%、CERBB-2（2+） 。依据患者病情及肿瘤病理与分期继续术后辅助性化疗指征存在，患者及家属拒绝化疗。自术后出院以来，患者一般情况保持良好；无发热，偶有恶心，无呕吐，无反酸、嗳气，无明显进食不适，偶有进食后轻微腹胀，无腹痛。现患者为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“胃恶性肿瘤术后”收入院。目前患者精神及情绪状态良好，食欲较术前明显减少，饮食可，夜间睡眠后；今8个月体重减轻18KG。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 7, "end_pos": 9}, {"end_pos": 34, "label_type": "手术", "overlap": 0, "start_pos": 29}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 78}, {"end_pos": 138, "label_type": "手术", "overlap": 0, "start_pos": 126}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 164, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 291}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 474, "label_type": "解剖部位", "overlap": 0, "start_pos": 473}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 508, "end_pos": 515}]}
{"originalText": "，患者3月余前于我院诊断为“直肠癌”，于2015-10-26在全麻上行腹腔镜直肠癌根治术，，术后病理示：，201518502：（直肠）腺癌（中度分化），浸润溃疡型，体积2.7*2*0.8CM，侵达浆膜。 双端切线及另送“近切线”、“远切线”未查见癌。 肠壁一站（6个）、中间组（3个）、中央组（3个）淋巴结未查见癌。低级别腺管状腺瘤。，免疫组化染色示：TS部分（+）、SYN（-）。，术后病理分期：PT3N0M0，II期，DUKES B。依情2015-11-08.2015-12-09给予奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1G D2-6 静滴，同时辅以镇吐、升血、免疫调节等对症支持治疗。化疗过程总体顺利。现为复查化疗来我院，门诊以“直肠癌术后”收入院。目前患者精神好，食欲及饮食好，夜间睡眠良好，小便正常，大便4-5次/天，基本成形。否认近期明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 44, "label_type": "手术", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 63, "end_pos": 81}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 126, "end_pos": 153}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 158, "end_pos": 166}, {"end_pos": 248, "label_type": "药物", "overlap": 0, "start_pos": 244}, {"end_pos": 261, "label_type": "药物", "overlap": 0, "start_pos": 257}, {"end_pos": 275, "label_type": "药物", "overlap": 0, "start_pos": 272}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 331, "end_pos": 336}]}
{"originalText": "，患者因“结肠癌”于2012-12-13在我院于全麻上行右半结肠切15除术，手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好，切口愈合良好，，术后病理：13862.2012结肠腺癌（中度分化），溃疡型，面积6.5*3.5，侵达浆膜脂肪组织。双端切线未查见癌。结肠腺管状腺瘤。呈肠壁一站（1/5个）淋巴结癌转移。肠壁二站（3个）淋巴结未查见癌。，免疫组化染色示癌组织：ERCC1(+)、TS少数细胞（+）。（PT4AN1M0，IIIA，DUCKS C）。后患者恢复好出院，术后给予化疗2周期。   院外期间患者一般情况好，无恶心，无腹痛腹胀胀不适，现患者为行复查及化疗再次来院就诊，门诊以“结肠癌术后”收入院。   近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"end_pos": 37, "label_type": "手术", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 89, "end_pos": 103}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 132, "end_pos": 139}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 154}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 169}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 270}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 297, "end_pos": 302}]}
{"originalText": "，缘于入院前4月余因中下腹部闷痛不适伴排黑便于我院就诊，诊断为“胃癌”，于2014年06月06日在全麻上行“腹腔镜辅助上根治性远端胃大部切除术（ROUX-Y吻合术D2）”手术顺利。术后病理（201417771），：“（远端胃）胃体小弯早期（IIC型）低分化腺癌，部分为印戒细胞癌，侵及粘膜上层，手术标本下、上切端及另送（下切端）均未见癌浸润。找到小弯淋巴结5个，大弯淋巴结5个，幽门下淋巴结18个，幽门上淋巴结3个，及另送（第8P组）淋巴结2个，均未见癌转移。另送（胃右动脉根部淋巴结）为脂肪、脉管及神经组织。，免疫组化结果：CK(L)（+++），CD68（组织细胞+），KI67（50%+）”，术后给予对症、抗感染治疗，恢复良好,伤口愈合良好。分别于2014.07.16、2014.08.13、2014.09.17、2014.10.29予“奥沙利铂（齐沙）150MGIVGTTD1+替吉奥胶囊（艾奕）40MGPOBIDD2-15”方案行术后第1、2、3、4周期化疗，化疗过程顺利。今为第5周期化疗再次入院。自下次出院后饮食、睡眠可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 32, "end_pos": 34}, {"end_pos": 71, "label_type": "手术", "overlap": 0, "start_pos": 54}, {"end_pos": 83, "label_type": "手术", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 108, "end_pos": 139}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 205, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 375, "label_type": "药物", "overlap": 0, "start_pos": 371}, {"end_pos": 378, "label_type": "药物", "overlap": 0, "start_pos": 376}, {"end_pos": 397, "label_type": "药物", "overlap": 0, "start_pos": 392}, {"end_pos": 400, "label_type": "药物", "overlap": 0, "start_pos": 398}, {"end_pos": 469, "label_type": "解剖部位", "overlap": 0, "start_pos": 468}, {"end_pos": 472, "label_type": "解剖部位", "overlap": 0, "start_pos": 471}]}
{"originalText": "，缘于入院前5月余因“反复返酸、嗳气7年”就诊我院，，行胃镜检查示：“1.胃窦癌2.慢性萎缩性胃炎”，，病理示：“胃管状腺癌II-III级”，下腹部平扫+，增强示：“胃肿瘤，伴腹腔、腹膜后多发淋巴结肿大”，考虑肿瘤局部较晚期，遂于2015.04.18、2015.05.11、2015.06.02、2015.06.29、2015.08.02予“安素泰210MGIVGTTD1+奥沙利铂（艾恒）150MGIVGTTD2+希罗达1000MGBIDPOD1-14”方案新辅助化疗，辅以止吐、制酸、保胃、保肝、营养支持等治疗。化疗后未见明显骨髓抑制，一般情况尚可。并于入院前1月余（2015.09.01）全麻上行“腹腔镜上根治性远端胃大部切除术”。术顺，术后恢复可，，术后病理：(远端胃)，：胃体及胃窦小弯侧早期隆起型（0-I型）低黏附性癌，印戒细胞癌为主，部分为低分化腺癌及未分化癌，浸润脉管及神经组织，脉管内见癌栓，侵及黏膜上层。标本下切端、上切端及另送(下切端)，均未见癌浸润。找到小弯侧淋巴结0/13个，大弯侧淋巴结2/10个，幽门下淋巴结1/4个，幽门上淋巴结5/6个，另送(胃右动脉根部）淋巴结2/8个，(胃壁)淋巴结0/4个，见癌转移。，免疫组化染色结果：CK(PAN)（+++），E-CADHERIN（+++），CDX-2（+++），CGA（+），CD56（-），SY（-），HER-2（-）。门诊拟“胃窦术后化疗”收入院。自发病以来，精神、睡眠可，食欲一般，大小便如常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 37, "end_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 42, "end_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 69}, {"label_type": "影像检查", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 86}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 99}, {"end_pos": 174, "label_type": "药物", "overlap": 0, "start_pos": 171}, {"end_pos": 191, "label_type": "药物", "overlap": 0, "start_pos": 187}, {"end_pos": 194, "label_type": "药物", "overlap": 0, "start_pos": 192}, {"end_pos": 211, "label_type": "药物", "overlap": 0, "start_pos": 208}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 265, "end_pos": 269}, {"end_pos": 317, "label_type": "手术", "overlap": 0, "start_pos": 302}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 341, "end_pos": 387}, {"end_pos": 445, "label_type": "解剖部位", "overlap": 0, "start_pos": 439}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}, {"end_pos": 469, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 474}, {"end_pos": 498, "label_type": "解剖部位", "overlap": 0, "start_pos": 487}, {"end_pos": 510, "label_type": "解剖部位", "overlap": 0, "start_pos": 503}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 604, "end_pos": 610}]}
